UNSPSC 51332002: Lintopride

This classification denotes a serotonin antagonist and antiemetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C2R0GEU722. European Medicines Agency schedules Lintopride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08526MIG. Lintopride generally arises in the molecular formula C14H19CLN4O2.

UNSPSC 51332002 Lintopride is a Commodity code covering pharmaceutical products, specifically naloxone and related drug-deactivation systems procured by state and local health agencies. The code currently reflects demand from county health departments purchasing naloxone—an opioid antagonist—and complementary drug disposal or neutralization systems to support overdose response and substance-abuse mitigation initiatives. Issuing bodies under this code include county health agencies and community health departments operating public health programs.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023. The procurement called for quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with vendors required to include all shipping and delivery costs in their bids and comply with drug-free workplace certification, E-Verify requirements, and applicable federal regulations including the Clean Air Act. The contract structure included a two-year initial term with a one-year renewal option and a three-month probationary period. Recent sourcing activity under the code is limited, with only this single documented state or local opportunity in the dataset.